Evidence map›Paper›PMID 38184290›Full record

ArticleAmerican journal of obstetrics and gynecology2024

Modeling delay of age at natural menopause with planned tissue cryopreservation and autologous transplantation.

Joshua Johnson, Sean D Lawley, John W Emerson, Kutluk H Oktay

Open access · bronzeAbstract read
In one paragraph

Article in American journal of obstetrics and gynecology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Elective Egg Freezing for Non-Medical Reasons (Scientific Impact Paper No. 63, 2026 Second Edition).BJOG : an international journal of obstetrics and gynaecology · 2026
    Article
  2. Review
  3. Cryopreservation of Rodent Ovarian Tissues and Oocytes.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Premature ovarian insufficiency.Nature reviews. Disease primers · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Joshua JohnsonDepartment of Obstetrics and Gynecology, University of Colorado School of Medicine (Anschutz Medical Campus), Aurora, CO.
Sean D LawleyDepartment of Mathematics, University of Utah, Salt Lake City, UT.
John W EmersonDepartment of Statistics and Data Science, Yale University, New Haven, CT.
Kutluk H OktayInnovation Institute for Fertility Preservation, New York, NY and New Haven, CT; Division of Reproductive Endocrinology, Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT. Electronic address: info@fertilitypreservation.org.
Yale University · USUniversity of Colorado Anschutz Medical Campus · USUniversity of Utah · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Characterization & Prevention of Chemotherapy-Induced Damage to Ovarian ReserveR01HD053112 · NICHD · YALE UNIVERSITY · PI KUTLUK H OKTAY · 2007 to 2026
$7.6M
Improving Primordial Follicle Survival After Transplantation of Cryopreserved HumR21HD061259 · NICHD · NEW YORK MEDICAL COLLEGE · PI OKTAY, KUTLUK H · 2011 to 2012
$443k
NCATS NIH HHS UL1 TR001863NICHD NIH HHS R01 HD053112NICHD NIH HHS R21 HD061259
6 · The paper itself

Abstract

backgroundOvarian tissue cryopreservation has been proven to preserve fertility against gonadotoxic treatments. It has not been clear how this procedure would perform if planned for slowing ovarian aging.

objectiveThis study aimed to determine the feasibility of cryopreserving ovarian tissue to extend reproductive life span and delay menopause by autotransplantation near menopause. STUDY

designBased on the existing biological data on follicle loss rates, a stochastic model of primordial follicle wastage was developed to determine the years of delay in menopause (denoted by D) by ovarian tissue cryopreservation and transplantation near menopause. Our model accounted for (1) age at ovarian tissue harvest (21-40 years), (2) the amount of ovarian cortex harvested, (3) transplantation of harvested tissues in single vs multiple procedures (fractionation), and (4) posttransplant follicle survival (40% [conservative] vs 80% [improved] vs 100% [ideal or hypothetical]).

resultsOur model predicted that, for most women aged <40 years, ovarian tissue cryopreservation and transplantation would result in a significant delay in menopause. The advantage is greater if the follicle loss after transplant can be minimized. As an example, the delay in menopause (D) for a woman with a median ovarian reserve who cryopreserves 25% of her ovarian cortex at the age of 25 years and for whom 40% of follicles survive after transplantation would be approximately 11.8 years, but this extends to 15.5 years if the survival is 80%. As another novel finding, spreading the same amount of tissue to repetitive transplants significantly extends the benefit. For example, for the same 25-year-old woman with a median ovarian reserve, 25% cortex removal, and 40% follicle survival, fractionating the transplants to 3 or 6 procedures would result in the corresponding delay in menopause (D) of 23 or 31 years. The same conditions (3 or 6 procedures) would delay menopause as much as 47 years if posttransplant follicle survival is improved to 80% with modern approaches. An interactive Web tool was created to test all variables and the feasibility of ovarian tissue freezing and transplantation to delay ovarian aging (here).

conclusionOur model predicts that with harvesting at earlier adult ages and better transplant techniques, a significant menopause postponement and, potentially, fertile life span extension can be achieved by ovarian tissue cryopreservation and transplantation in healthy women.

Indexed as

CryopreservationFertility PreservationAdultFemaleHumansMenopauseOvarian FollicleOvaryTransplantation, Autologousfertility extensionfertility preservationmenopausal symptomsmenopausemenopause delayovarian tissue cryopreservationovary

Identifiers

PMID38184290
PMCPMC11625473
OpenAlexW4390590720

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.